Curtis J. Henrich, Ph.D.

Team Member of:
Dr. Henrich coordinates bioassay development, high-throughput screening, and application of assays to natural products isolation within the Molecular Targets Program.
1) bioassay development, 2) high-throughput screening, 3) natural products isolation
Contact Info
Center for Cancer Research
National Cancer Institute
Building 567, Room 219
Frederick, MD 21702-1201
Ph: 301-846-6054
henrichcj@mail.nih.gov
Coordination of bioassay development, high-throughput screening, and application of assays to natural products isolation.
Selected Publications
- Nat Prod Rep. 30: 1284-98, 2013. [ Journal Article ]
- Biochem. Pharmacol.. 88: 313-21, 2014. [ Journal Article ]
- Phytochem Lett. 7: 42-45, 2014. [ Journal Article ]
- Chem Biol Drug Des. 82: 131-9, 2013. [ Journal Article ]
- J. Nat. Prod.. 76: 59-63, 2013. [ Journal Article ]
Dr. Henrich received his Ph.D. in biochemistry from the University of Michigan (thesis research on erythrocyte senescence-related glycoconjugates). He conducted his postdoctoral research in Michigan and at the University of California, San Francisco, which was followed by 14 years in the biotechnology industry (Life Technologies, Inc. and a now defunct start-up called Aptus Pharmaceuticals). He joined the Molecular Targets Program (formerly, Molecular Targets Laboratory) in 2003 first as a Consultant, then as a Senior Scientist affiliated with Leidos Biomedical Research, Inc. (formerly, SAIC-Frederick, Inc.)
Name | Position |
---|---|
Mohammadnabi Asmani Ph.D. | Postdoctoral Fellow (CRTA) |
Nirmala Sharma | Biologist |
Emily Smith M.S. | Research Associate (Leidos) |
Nicolle Viloria | Postbaccalaureate Fellow (CRTA) |
Antony Wamiru | Senior Research Technician (Leidos) |
Jennifer A. Wilson | Biological Lab Technician |
Girma M. Woldemichael, Ph.D. | Scientist II (Leidos) |